Skip to content
Citeline Podcasts cover art

All Episodes

Citeline Podcasts — 625 episodes · page 2 of 7

#
Title
101

The Generics Bulletin Podcast: Green Regulations With Medicines for Europe’s Adrian van den Hoven

102

Drug Fix: CBER Director Candidate Emerges, US FDA Promotes Leucovorin Pathway

103

성숙기 진입 중인 ADC 시장…삼성바이오에피스, 차별화 전략 강화 (Korean-language podcast) Apr. 17, 2026

104

Japan Q1 Roundup: Key Commercial and Policy/Regulatory Developments

105

Lilly TuneLab: Breaking Data Silos in Biotech with Federated Learning

106

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Apr. 10, 2026

107

Scrip's Five Must-Know Things - Apr. 13, 2026

108

Drug Fix: Leucovorin’s Resurrection, PhRMA’s Leadership Change

109

No Matter What: How Israel Is Positioning Itself as a Global Pharma Innovation Hub

110

Inside Step Pharma’s Pan‑Cancer Ambition

111

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Apr. 6, 2026

112

Scrip's Five Must-Know Things - Apr. 6, 2026

113

China Biopharma English-Language Podcast: China’s Regulatory Changes In Cell Therapy

114

Five-Minute Podcast: “UK Needs To Align More With The EU”

115

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Mar. 30, 2026

116

Why Longevity Is The Next Big OTC Opportunity, With Euromonitor’s Magda Starula

117

Scrip's Five Must-Know Things - Mar.30, 2026

118

Drug Fix: US FDA Commissioner Martin Makary Completes First Year In Charge

119

Lupin’s CEO And MD On GLP-1 Strategy, Business Growth And Legacy

120

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Mar.23, 2026

121

Scrip's Five Must-Know Things - Mar.23, 2026

122

Drug Fix: ACIP Next Steps After Judge Stops Work, Potential Opioid Disposal Changes

123

How a CDMO Created a Custom Vaccine Development Project

124

뇌질환 신약 개발 펀딩 부활 조짐 (Korean-language podcast) Mar.19, 2026

125

The Generics Bulletin Podcast: 2026 Conferences

126

Winning In The Probiotics Space, With David Pineda Ereño

127

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Mar.16, 2026

128

Scrip's Five Must-Know Things - Mar.16, 2026

129

Drug Fix: US FDA’s Prasad Leaves, Harry Potter, And Is CNPV Effective Because Of RTOR?

130

Killing Cancer Loudly: Onchilles Pharma's Neutrophil-Derived Path to Pan-Cancer Therapy

131

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Mar.9, 2026

132

Scrip's Five Must-Know Things - Mar.9, 2026

133

Drug Fix: The State Of Facility Inspections With Two Former Senior US FDA Execs

134

Unpacking Europe’s Probiotic Rules with David Pineda Ereño

135

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Mar. 2, 2026

136

Scrip's Five Must-Know Things - Mar.2, 2026

137

Drug Fix: State Of The Generics Industry, US FDA Commissioner On Compassionate Use

138

Affibody and the Case for Antibody Mimetics in Radioligand Therapy

139

글로벌 제약업계, 2026년 역풍 직면…최혜국 약가정책 영향은 제한적 (Korean-language podcast) Feb.25, 2026

140

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Feb. 24, 2026

141

Scrip's Five Must-Know Things - Feb.24, 2026

142

Drug Fix: ‘America First’ US FDA User Fees, Moderna’s Flu Vaccine Saga Continues

143

Hansa Biopharma On Clearing The Path To Kidney Transplant

144

ESG, Eco‑Pricing and Sustainable Packaging, with Steve Ramus

145

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Feb. 16, 2026

146

Scrip's Five Must-Know Things - Feb.16, 2026

147

Drug Fix: US FDA Versus Moderna And The Changing Role Of Refuse To File Actions

148

Preventing Lung Disease in Preterm Babies

149

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Feb. 9 , 2026

150

Scrip's Five Must-Know Things - Feb. 9, 2026

151

Drug Fix: US FDA Hiring Improves, But Can The Agency Avoid Oversight Erosion?

152

Navigating A Changing EU And US Sustainability Landscape, With Steve Ramus

153

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Feb.2, 2026

154

Scrip's Five Must-Know Things - Feb. 2, 2026

155

Drug Fix: Understanding US FDA’s CNPV Application Reviews

156

How Senti Bio's Programmable Cell Therapy Tackles AML's Toxicity Problem

157

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Jan.26, 2026

158

Scrip's Five Must-Know Things - Jan. 26, 2026

159

Scrip JPM Podcast: Dealmaking, Regulatory And Commercial Expectations For 2026

160

Drug Fix: US FDA Review Speed Steady In 2025, But Will Staffing Impact In 2026?

161

Herantis’s ‘Elegant’ Approach In Parkinson’s

162

【3分で解説 #世界のファーマ】第28回 ノバルティスが警鐘 自国第一主義の弊害へ (Japanese-language podcast)

163

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Jan.19, 2026

164

Scrip's Five Must-Know Things - Jan. 19, 2026

165

Drug Fix: Pazdur’s CNPV Problems, Could US FDA Release Unapproved Product Action Packages?

166

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Jan.13, 2026

167

Scrip이 묻다: 2026년 바이오의약품 업계 전망은? 자본배분과 딜메이킹 (Korean-language podcast)

168

Scrip's Five Must-Know Things - Jan. 13, 2026

169

Drug Fix: Oncology Stalwart Richard Pazdur Leaves US FDA

170

Building a Nasal First line of Defense Against H5N1

171

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

172

Scrip's Five Must-Know Things - Dec. 22, 2025

173

“We Are On The Cusp Of A Real Revolution”: OHC Rare Disease Center Boosts Innovation

174

Scrip Awards Podcast, 2025 Winners

175

Datamonitor Healthcare Podcast: A Deep Dive into Dry AMD

176

Scrip M&A Podcast: PwC's Dealmaking Preview for 2026

177

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

178

Scrip's Five Must-Know Things - Dec. 15, 2025

179

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

180

Scrip's Five Must-Know Things - Dec. 8, 2025

181

Overcoming Drug Resistance In Oncology With Kairos Pharma's Neil Bhowmick

182

Drug Fix: Understanding the US FDA’s CDER Leadership Shuffle

183

【3分で解説 #世界のファーマ】第27回 中国バイオ企業の成長 5つのテーマ (Japanese-language podcast)

184

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

185

Scrip's Five Must-Know Things - Dec. 1, 2025

186

글로벌 바이오 리더들, M&A 열기 속 낙관론 확산 (Korean-language podcast)

187

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

188

Scrip's Five Must-Know Things - Nov. 25, 2025

189

Charles River CSO Calls For Collaboration On Non-Animal Models

190

Over The Counter Special: Enabling Digital Self-Care, With PAGB’s Michelle Riddalls

191

Digital Health Roundup: BCIs Surge Ahead, Oura Eyes BP Clearance, AI Faces New Scrutiny

192

Over The Counter Special: Unlocking Switch-Driven Growth, With PAGB’s Michelle Riddalls

193

Data-Driven Insights Reveal The Growth Engines Powering 2026 Life Sciences

194

EY's Arda Ural on IPOs, Financial Markets and Tarrifs

195

Datamonitor Healthcare Podcast: ESMO 2025

196

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

197

Scrip's Five Must-Know Things - Nov. 10, 2025

198

Drug Fix: Examining George Tidmarsh’s Departure As Head Of US FDA’s Drug Center

199

Podcast: Beyond The Checkpoint — Next-Gen Strategies In Immuno-Oncology

200

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)